BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 10618725)

  • 21. Tsg101 is upregulated in a subset of invasive human breast cancers and its targeted overexpression in transgenic mice reveals weak oncogenic properties for mammary cancer initiation.
    Oh KB; Stanton MJ; West WW; Todd GL; Wagner KU
    Oncogene; 2007 Aug; 26(40):5950-9. PubMed ID: 17369844
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of full-length p53 and its isoform Deltap53 in breast carcinomas in relation to mutation status and clinical parameters.
    Baumbusch LO; Myhre S; Langerød A; Bergamaschi A; Geisler SB; Lønning PE; Deppert W; Dornreiter I; Børresen-Dale AL
    Mol Cancer; 2006 Oct; 5():47. PubMed ID: 17054774
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The pathology of familial breast cancer: histological features of cancers in families not attributable to mutations in BRCA1 or BRCA2.
    Lakhani SR; Gusterson BA; Jacquemier J; Sloane JP; Anderson TJ; van de Vijver MJ; Venter D; Freeman A; Antoniou A; McGuffog L; Smyth E; Steel CM; Haites N; Scott RJ; Goldgar D; Neuhausen S; Daly PA; Ormiston W; McManus R; Scherneck S; Ponder BA; Futreal PA; Peto J; Stoppa-Lyonnet D; Bignon YJ; Stratton MR
    Clin Cancer Res; 2000 Mar; 6(3):782-9. PubMed ID: 10741697
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Low frequency of TSG101/CC2 gene alterations in invasive human breast cancers.
    Wang Q; Driouch K; Courtois S; Champème MH; Bièche I; Treilleux I; Briffod M; Rimokh R; Magaud JP; Curmi P; Lidereau R; Puisieux A
    Oncogene; 1998 Feb; 16(5):677-9. PubMed ID: 9482115
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of truncated FHIT transcripts in cervical cancers and in normal human cells.
    Matthews CP; Shera K; Kiviat N; McDougall JK
    Oncogene; 2001 Aug; 20(34):4665-75. PubMed ID: 11498789
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Detailed deletion mapping in sporadic breast cancer at chromosomal region 17p13 distal to the TP53 gene: association with clinicopathological parameters.
    Seitz S; Poppe K; Fischer J; Nothnagel A; Estévez-Schwarz L; Haensch W; Schlag PM; Scherneck S
    J Pathol; 2001 Jul; 194(3):318-26. PubMed ID: 11439364
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Alternative and aberrant messenger RNA splicing of the mdm2 oncogene in invasive breast cancer.
    Lukas J; Gao DQ; Keshmeshian M; Wen WH; Tsao-Wei D; Rosenberg S; Press MF
    Cancer Res; 2001 Apr; 61(7):3212-9. PubMed ID: 11306511
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association of p53 gene alterations with the expression of antiapoptotic survivin splice variants in breast cancer.
    Végran F; Boidot R; Oudin C; Defrain C; Rebucci M; Lizard-Nacol S
    Oncogene; 2007 Jan; 26(2):290-7. PubMed ID: 16847456
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interest of investigating p53 status in breast cancer by four different methods.
    Thirion A; Rouanet P; Thezenas S; Detournay D; Grenier J; Lopez-Crapez E
    Oncol Rep; 2002; 9(6):1167-72. PubMed ID: 12375013
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Analysis of the correlation between genetic and immunohistochemical markers (RB1, p16 and p53 gene regultors of a cell cycle) in sporadic mammary gland carcinoma].
    Nemtsova MV; Zemliakova VV; Kuznetsova EV; Babenko OV; Zavalishina LE; Andreeva IuIu; Bateva MV; Frank GA; Zaletaev DV
    Arkh Patol; 2007; 69(2):3-6. PubMed ID: 17642181
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Breast cancer patients with p53 Pro72 homozygous genotype have a poorer survival.
    Tommiska J; Eerola H; Heinonen M; Salonen L; Kaare M; Tallila J; Ristimäki A; von Smitten K; Aittomäki K; Heikkilä P; Blomqvist C; Nevanlinna H
    Clin Cancer Res; 2005 Jul; 11(14):5098-103. PubMed ID: 16033823
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A putative tumor suppressor, TSG101, acts as a transcriptional suppressor through its coiled-coil domain.
    Watanabe M; Yanagi Y; Masuhiro Y; Yano T; Yoshikawa H; Yanagisawa J; Kato S
    Biochem Biophys Res Commun; 1998 Apr; 245(3):900-5. PubMed ID: 9588212
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mutant p53 protein overexpression in women with ipsilateral breast tumor recurrence following lumpectomy and radiation therapy.
    Turner BC; Gumbs AA; Carbone CJ; Carter D; Glazer PM; Haffty BG
    Cancer; 2000 Mar; 88(5):1091-8. PubMed ID: 10699900
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Overexpression of WNT2 and TSG101 genes in colorectal carcinoma.
    Ma XR; Edmund Sim UH; Pauline B; Patricia L; Rahman J
    Trop Biomed; 2008 Apr; 25(1):46-57. PubMed ID: 18600204
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Relationship between expressions of telomerase genes and apoptosis related genes in mammary ductal atypical hyperplasia].
    Song M; Li BL; Mi XY; Gao YX; Song JY
    Ai Zheng; 2002 May; 21(5):484-8. PubMed ID: 12452037
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Modulation of signal transducer and activator of transcription 3 activities by p53 tumor suppressor in breast cancer cells.
    Lin J; Jin X; Rothman K; Lin HJ; Tang H; Burke W
    Cancer Res; 2002 Jan; 62(2):376-80. PubMed ID: 11809683
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Heterogeneous gene alterations in primary breast cancer contribute to discordance between primary and asynchronous metastatic/recurrent sites: HER2 gene amplification and p53 mutation.
    Sekido Y; Umemura S; Takekoshi S; Suzuki Y; Tokuda Y; Tajima T; Osamura RY
    Int J Oncol; 2003 Jun; 22(6):1225-32. PubMed ID: 12738987
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunohistochemical detection of p53 protein expression in breast cancer in young Kuwaiti women.
    Temmim L; Baker H; Sinowatz F
    Anticancer Res; 2001; 21(1B):743-8. PubMed ID: 11299837
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Aberrant expression of TSG101 in Taiwan Chinese breast cancer.
    Lo YF; Chen TC; Chen SC; Chao CC
    Breast Cancer Res Treat; 2000 Apr; 60(3):259-66. PubMed ID: 10930114
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Negative regulation of chemokine receptor CXCR4 by tumor suppressor p53 in breast cancer cells: implications of p53 mutation or isoform expression on breast cancer cell invasion.
    Mehta SA; Christopherson KW; Bhat-Nakshatri P; Goulet RJ; Broxmeyer HE; Kopelovich L; Nakshatri H
    Oncogene; 2007 May; 26(23):3329-37. PubMed ID: 17130833
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.